Atul R Mahableshwarkar

Summary

Publications

  1. doi request reprint A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
    Atul R Mahableshwarkar
    Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Med Res Opin 29:217-26. 2013

Detail Information

Publications1

  1. doi request reprint A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
    Atul R Mahableshwarkar
    Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA
    Curr Med Res Opin 29:217-26. 2013
    ..This trial assessed the efficacy and tolerability of 2.5 and 5 mg vortioxetine for the treatment of MDD...